Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Return on Invested Capital (2017 - 2025)

Organogenesis Holdings (ORGO) has 9 years of Return on Invested Capital data on record, last reported at 0.16% in Q4 2025.

  • For Q4 2025, Return on Invested Capital rose 16.0% year-over-year to 0.16%; the TTM value through Dec 2025 reached 0.16%, up 16.0%, while the annual FY2025 figure was 0.16%, 16.0% up from the prior year.
  • Return on Invested Capital reached 0.16% in Q4 2025 per ORGO's latest filing, up from 0.01% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.45% in Q2 2021 and bottomed at 0.06% in Q1 2025.
  • Average Return on Invested Capital over 5 years is 0.11%, with a median of 0.05% recorded in 2023.
  • Peak YoY movement for Return on Invested Capital: soared 94bps in 2021, then fell -30bps in 2022.
  • A 5-year view of Return on Invested Capital shows it stood at 0.28% in 2021, then crashed by -77bps to 0.06% in 2022, then crashed by -54bps to 0.03% in 2023, then crashed by -95bps to 0.0% in 2024, then soared by 10992bps to 0.16% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Invested Capital were 0.16% in Q4 2025, 0.01% in Q3 2025, and 0.04% in Q2 2025.